These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25128205)

  • 1. The WERCAP Screen and the WERC Stress Screen: psychometrics of self-rated instruments for assessing bipolar and psychotic disorder risk and perceived stress burden.
    Mamah D; Owoso A; Sheffield JM; Bayer C
    Compr Psychiatry; 2014 Oct; 55(7):1757-71. PubMed ID: 25128205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.
    Hsieh CJ; Godwin D; Mamah D
    Front Psychiatry; 2016; 7():149. PubMed ID: 27616996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion.
    Mamah D; Mutiso VN; Ndetei DM
    Schizophr Res; 2022 Mar; 241():201-209. PubMed ID: 35144059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychometric properties of the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) screen in adults in the Kenyan context: Towards combined large scale community screening for affectivity and psychosis.
    Ndetei D; Pike K; Mutiso V; Tele A; Gitonga I; Rebello T; Musyimi C; Mamah D
    Psychiatry Res; 2019 Dec; 282():112569. PubMed ID: 31727439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents.
    Mamah D; Musau A; Mutiso VN; Owoso A; Abdallah AB; Cottler LB; Striley CW; Walker EF; Ndetei DM
    Schizophr Res; 2016 Oct; 176(2-3):340-348. PubMed ID: 27522263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation.
    Van Meter A; Guinart D; Bashir A; Sareen A; Cornblatt BA; Auther A; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Cascio NL; Correll CU
    J Affect Disord; 2019 Apr; 249():357-365. PubMed ID: 30807937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years.
    Kotzalidis GD; Solfanelli A; Piacentino D; Savoja V; Fiori Nastro P; Curto M; Lindau JF; Masillo A; Brandizzi M; Fagioli F; Raballo A; Gebhardt E; Preti A; D'Alema M; Fucci MR; Miletto R; Andropoli D; Leccisi D; Girardi P; Loewy RL; Schultze-Lutter F
    Schizophr Res; 2017 Nov; 189():50-56. PubMed ID: 28254200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition.
    Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J
    Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing self-reported clinical high risk symptoms in community-derived adolescents: A psychometric evaluation of the Prodromal Questionnaire-Brief.
    Fonseca-Pedrero E; Gooding DC; Ortuño-Sierra J; Paino M
    Compr Psychiatry; 2016 Apr; 66():201-8. PubMed ID: 26995254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis risk screening in youth: a validation study of three self-report measures of attenuated psychosis symptoms.
    Kline E; Wilson C; Ereshefsky S; Denenny D; Thompson E; Pitts SC; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2012 Oct; 141(1):72-7. PubMed ID: 22921375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms.
    Guinart D; de Filippis R; Rosson S; Patil B; Prizgint L; Talasazan N; Meltzer H; Kane JM; Gibbons RD
    Schizophr Bull; 2021 Apr; 47(3):644-652. PubMed ID: 33164091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Strauss GP; Chapman HC
    Schizophr Res; 2018 Mar; 193():435-437. PubMed ID: 28779853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal validation of psychosis risk screening tools.
    Kline E; Thompson E; Demro C; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2015 Jul; 165(2-3):116-22. PubMed ID: 25975827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) for identifying attenuated psychosis syndrome in a college population.
    Chen F; Wang L; Wang J; Heeramun-Aubeeluck A; Yuan J; Zhao X
    Early Interv Psychiatry; 2016 Aug; 10(4):308-15. PubMed ID: 25113068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirming the structure of negative beliefs about psychosis and bipolar disorder: A confirmatory factor analysis study of the Personal Beliefs about Experience Questionnaire and Personal Beliefs about Illness Questionnaire.
    Taylor PJ; Pyle M; Schwannauer M; Hutton P; Morrison A
    Br J Clin Psychol; 2015 Nov; 54(4):361-77. PubMed ID: 25752586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic symptoms in patients with bipolar mania.
    Canuso CM; Bossie CA; Zhu Y; Youssef E; Dunner DL
    J Affect Disord; 2008 Dec; 111(2-3):164-9. PubMed ID: 18378001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSM-5 conduct disorder and symptoms in youths at high risk of psychosis in Kenya with DSM-5 mental disorders and substance use: towards integrated management.
    Ndetei DM; Mutiso V; Musyimi C; Momanyi R; Nyamai P; Tyrer P; Mamah D
    Sci Rep; 2023 Dec; 13(1):22889. PubMed ID: 38129579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population.
    Kobayashi H; Nemoto T; Koshikawa H; Osono Y; Yamazawa R; Murakami M; Kashima H; Mizuno M
    Schizophr Res; 2008 Dec; 106(2-3):356-62. PubMed ID: 18809299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.